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Aims Intravascular ultrasound (IVUS) assesses arterial remodelling by comparing the lesion external
elastic membrane (EEM) with the reference segments; however, reference segments are rarely
disease-free. The aim was to assess lesion and reference segment remodelling and plaque burden in
patients with type-2 diabetes mellitus.
Methods and results We used pre-intervention IVUS to study 62 de novo lesions in 43 patients with
type-2 diabetes mellitus. The lesion site was the image slice with the smallest lumen cross-sectional
area (CSA). The proximal and distal reference segments were the most normal-looking segments
within 5 mm proximal and distal to the lesion. Plaque burden was measured as plaque CSA/EEM CSA.
The remodelling index was deﬁned as lesion EEM CSA/mean reference EEM CSA. Reference segment
plaque burden measured 0.54+0.09. The majority of lesions (83.9%) had negative remodelling
(lesion EEM, reference). Similarly, the slope of the regression line relating EEM to plaque CSA within
the lesion was less than the reference substantiating negative remodelling. The reference segment
plaque burden correlated inversely with the difference between IVUS lumen and quantitative coronary
angiographic artery size [slope ¼ 20.12 (95% CI 20.17 to 20.07); P , 0.001] in all patients with type-2
diabetes mellitus.
Conclusion Lesions in type-2 diabetic patients are different from previous reports in non-diabetics.
Lesions in type-2 diabetics are characterized by a large reference segment plaque burden and negative
lesion site remodelling. These IVUS ﬁndings may explain the angiographic appearance of small arteries
in diabetic patients.
KEYWORDS
Remodelling;
Diabetes;
Intravascular ultrasound;
Reference vessel
Introduction
The term arterial remodelling refers to changes in vascular
dimensions during the development of atherosclerosis.
Remodelling can be either positive (when the vascular
area increases as plaque develops) or negative (when
the vascular area decreases as plaque develops).1 Intravas-
cular ultrasound (IVUS) assesses arterial remodelling by
comparing the lesion external elastic membrane (EEM)
with the reference segments to generate a remodelling
index (RI); however, reference segments are rarely disease-
free, typically have a signiﬁcant plaque burden, and,
therefore, may also have undergone remodelling changes.
Remodelling has been studied in vitro2 as well as in vivo
using IVUS.3–9 Factors that have been shown to
affect the RI include hypercholesterolaemia,10–12
diabetes,13 and the clinical presentation of coronary artery
disease.8,14–16 The present study assesses lesion and refer-
ence segment remodelling and plaque burden in patients
with type-2 diabetes mellitus.
Methods
Study population
From February 2005 to March 2006, 43 patients with type-2 diabetes
mellitus and angiographically signiﬁcant coronary stenoses in native
coronary arteries were included. Use of IVUS before coronary inter-
vention was at the operator’s discretion, but no pre-dilation was
allowed. The patients in the current analysis were from a study of
150 diabetic patients randomized to Cypher vs. Taxus stents. The
including criteria for the randomized stent study were reference
segment  2.0 mm and acceptance from the patient to have an
8 month IVUS follow up. Excluding criteria were vein grafts and
intolerance to aspirin or clopidogrel. Pre-intervention IVUS was
attempted in 43 patients in whom the treatment lesion was not
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deemed too tight to perform pre-intervention imaging; it was
successful in all the 43 patients.
Severely calciﬁc lesions and ostial lesions were not included in the
study. All patients provided written, informed consent, and the
local institutional review board (The Scientiﬁc Ethics Committee
for the County of Aarhus, Denmark) approved the protocol (case
no. 20040170).
Intravascular ultrasound imaging protocol
and analysis
Pre-intervention IVUS was performed after administration of 200 mg
intracoronary nitroglycerin. The IVUS system (Galaxy, Boston Scien-
tiﬁc, Fremont, CA, USA) utilized a 40 Mhz, 2.6 Fr IVUS catheter
(Atlantis-Pro). Image acquisition using automated transducer pull-
back at 0.5 mm/s was performed from at least 10 mm distal to
the lesion retrograde to the aorto-ostial junction. Ofﬂine analysis
was performed with a commercially available program for compu-
terized planimetry (EchoPlaque, INDEC System, Mountain View,
CA, USA).
For each 1 mm of axial length, lumen and EEM cross-sectional
areas (CSAs) were measured. The EEM was measured at the
leading edge of the adventitia. Plaque and media (P&M) CSA was
calculated as EEM CSA minus lumen CSA. Plaque burden was calcu-
lated as P&M CSA divided by EEM CSA. The lesion site was the image
slice with the smallest lumen CSA. Volumes were calculated using
Simpson’s rule.
The proximal and distal reference segments were the most
normal-looking segments (largest lumen with smallest plaque
burden) within 5 mm proximal and distal to the lesion (Figure 1).
RI was deﬁned as lesion EEM CSA divided by mean reference EEM
CSA. Negative remodelling was deﬁned as an RI, 0.95.
Quantitative coronary angiography
Siemens HICOR biplane catheterization equipment was used for cor-
onary angiography (Siemens Medical System, Inc., Germany). The
computer-based ACOM.PC V3.1 (Siemens Medical Systems, Inc.)
was used to perform quantitative coronary angiographic (QCA)
analysis ofﬂine. The reference diameter of the vessel and minimal
luminal diameter (MLD) were measured, and percent diameter ste-
nosis was calculated [12(MLD/reference segment diameter)100].
Statistical analysis
Categorical data are presented as counts and percentages, and con-
tinuous data are expressed as mean+SD.
The statistical analyses were performed by SAS 9.1 (Proc Mixed).
In order to take the multiple vessels within a patient into account,
subjects were speciﬁed as random factor, and the measurements at
different positions within a vessel (lesion, proximal reference, and
distal reference segments, respectively) were speciﬁed as the
repeated effect with a compound symmetry covariance structure.
Other covariance matrices were estimated by restricted maximum
likelihood. According to Akaikes information criteria, the compound
symmetry model was chosen. An additional random effect of vessel
within patient was estimated, but the corresponding variance com-
ponent was either zero or close to and therefore eliminated. This
Figure 1 Intravascular ultrasound imaging of a lesion showing negative remodelling. Proximal reference (left), lesion (centre), and distal reference (right).
Table 1 Baseline clinical characteristics
Number of patients 41
Number of lesions 62
Age, years 63.0+10.0
Males, n (%) 35 (85.4)
Blood pressure, mmHg
Systolic blood pressure 143.2+20.1
Diastolic blood pressure 74.9+11.7
Hypertension, n (%) 17 (41.5)
Cigarette smoking, n (%) 11 (26.5)
Body mass index, kg/m2 28.3+4.1
Insulin treatment, n (%) 8 (19.5)
Oral antidiabetic medication, n (%) 29 (70.7)
Insulin plus oral antidiabetic medication, n (%) 4 (9.8)
Clinical presentation, n (%)
Stable angina pectoris 34 (82.9)
ACS 7 (17.1)
HgbA1c, mmol/L 0.075+0.012
Lipid proﬁle, mmol/L
Total cholesterol 4.3+0.9
LDL cholesterol 2.3+0.8
HDL cholesterol 1.2+0.4
Triglyceride 2.1+1.3
Statin treatment, n (%) 30 (73.2)
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model was used to test whether there was a signiﬁcant change in
CSA (EEM, lumen, P&M, and plaque burden) measurements at the
three different positions: lesion, proximal reference, and distal
reference segments, respectively (position used as a ﬁxed effect).
The mixed model was used for the analysis of covariance (linear
regression). For this purpose, the repeated measurements within a
patient was used to estimate an unstructured covariance matrix.
The estimate for the covariate is called a slope in the presentation
and is reported together with a 95% CI.
For all the models used, the degree of freedom was estimated by
the method of Satterthwaite, and a probability value of ,0.05
(two-sided) was considered signiﬁcant.
Results
Baseline characteristics
We studied 62 de novo lesions in 41 patients with type-2 dia-
betes mellitus. Clinical features at baseline are shown in
Table 1. Eight patients were treated with insulin, 29 patients
were treated with oral antidiabetic medication, and four
patients were treated with insulin plus one or more oral
antidiabetic medications. Seven patients had acute coronary
syndrome (ACS) and 34 patients had stable angina pectoris.
Intravascular ultrasound measurements
IVUS measurements are shown in Table 2. Overall, EEM CSA
and lumen CSA were signiﬁcantly smaller at the lesion site
compared with the reference segments, whereas P&M CSA
and plaque burden were signiﬁcantly larger at the lesion
site compared with the reference segments.
Overall, RI was 0.85+0.13. The majority of lesions (84%)
had negative remodelling. There were seven patients with
two lesions (in two vessels) and seven patients with three
lesions (in three vessels). In 12 of these 14 patients, the
same remodelling pattern was seen in the multiple lesions
studied. Similarly, the slope of the regression line relating
EEM to P&M CSA within the lesion [slope ¼ 1.06 (95% CI
1.01–1.12); P , 0.001] was less than the reference
[slope ¼ 1.17 (95% CI 0.97–1.36); P , 0.001] (Figure 2), sub-
stantiating negative remodelling at the lesion site. The slope
of the regression line relating RI to P&M CSA within the
lesion was signiﬁcant [slope ¼ 0.020 (95% CI 0.012–0.027);
P , 0.001] but this was not the case when relating RI to
the reference segment P&M CSA [slope ¼ 0.009 (95% CI
20.003 to 0.021); P ¼ 0.13]. Lesion EEM CSA correlated sig-
niﬁcantly with mean reference EEM CSA [slope ¼ 0.94 (95%
CI 0.83–1.06); P, 0.001], and lesion P&M CSA correlated
signiﬁcantly with mean reference P&M CSA [slope ¼ 1.10
(95% CI 0.90–1.30); P, 0.001] (Figure 3).
When insulin-treated diabetics (whether or not they were
also being treated with an oral agent) were compared with
non-insulin-treated diabetics, RI was similar (0.82+0.13
vs. 0.86+0.12, P ¼ 0.25). Metabolic control (HgbA1c
level) was not related to RI (P ¼ 0.34). RI was also similar
when ACS patients were compared with stable patients
(0.89+0.18 vs. 0.84+0.11, P ¼ 0.35). RI was similar in
patients treated with a statin compared with no-lipid-
lowering treatment (0.82+0.10 vs. 0.87+0.11, P ¼ 0.20).
Plaque burden in reference segments
Reference segment plaque burden measured 0.54+0.10
(Figure 4): 0.55+0.11 for the proximal reference segment
and 0.53+0.11 for the distal reference segment. Eighteen
Figure 2 Relation between lesion external elastic membrane cross-sectional
area and plaque and media cross-sectional area, and the relation between
reference external elastic membrane cross-sectional area and plaque and
media cross-sectional area.
Table 2 Intravascular ultrasound measurements
Lesion Proximal reference Distal reference P
EEM CSA, mm2 11.9+3.9 14.4+4.1 13.4+3.8 ,0.001
Lumen CSA, mm2 2.9+0.8 6.5+2.7 6.1+1.9 ,0.001
P&M CSA, mm2 9.0+3.6 7.9+2.8 7.3+2.9 ,0.001
Plaque burden 0.74+0.08 0.55+0.11 0.53+0.11 ,0.001
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(44%) of the patients had a plaque burden of .60% in the
reference segment. The reference plaque burden was not
related to the pattern of remodelling [slope ¼ 0.13 (95% CI
20.05 to 0.31); P ¼ 0.14]. When insulin-treated diabetics
were compared with non-insulin-treated diabetics, refer-
ence segment plaque burden was similar (0.54+0.09 vs.
0.54+0.10, P ¼ 0.74). When ACS patients were compared
with stable patients, reference segment plaque burden
was similar (0.59+0.10 vs. 0.53+0.09, P ¼ 0.13).
Intravascular ultrasound volume measurements
and lipids
In each lesion, a 10 mm long segment of artery centred on
the minimum lumen site was analysed, and volumes were
calculated. EEM and P&M volumes correlated inversely
with total cholesterol, LDL cholesterol, and HDL cholesterol
(Table 3).
Quantitative coronary angiography vs.
intravascular ultrasound
The overall angiographic diameter stenosis measured
54.8+10.6%; the reference diameter measured 2.6+
0.4 mm (proximal reference ¼ 2.7+0.4 mm and distal
reference ¼ 2.5+0.4 mm); MLD measured 1.2+0.4 mm.
By IVUS, the reference lumen diameter was 2.81+
0.42 mm and the reference EEM diameter was 4.18+
0.56 mm. The plaque burden in the reference segment cor-
related inversely with the difference between IVUS lumen
and QCA artery size [slope ¼ 20.12 (95% CI 20.17 to
20.07); P, 0.001] in all patients with type-2 diabetes
mellitus (Figure 5). Angiographic reference diameter did
not correlate with IVUS plaque burdens, neither in insulin-
treated nor in non-insulin-treated patients.
Discussion
In the current study, lesions in type-2 diabetic patients dif-
fered from those in non-diabetics reported previously.
Type-2 diabetics had a larger reference segment plaque
burden and a high frequency (83%) of negative lesion site
remodelling, with 90% of the lesions having an EEM CSA
less than the reference. The remodelling pattern was
similar in diabetic patients with ACS vs. stable angina pec-
toris. Again, this is in contrast with studies in non-diabetics
(or studies containing a limited number of diabetic
patients), which showed that positive remodelling is more
frequently observed in culprit lesions of patients with ACS
and/or ruptured plaques, whereas negative remodelling
classiﬁcation is more commonly observed in target lesions
of patients with chronic stable angina.14,17–19 The analysis
in the present study applies only to angiographically stenotic
lesions in diabetics, not to angiographically occult (or insig-
niﬁcant) lesions.
Remodelling in diabetics vs. non-diabetics
Most studies have shown a high frequency of negative remo-
delling in diabetics, but the exact frequency varied from
Figure 4 Frequency distribution of the mean reference segment plaque
burden.
Figure 3 Relation between lesion external elastic membrane cross-sectional
area and reference external elastic membrane cross-sectional area, and the
relation between lesion plaque and media cross-sectional area and reference
plaque and media cross-sectional area.
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study to study and may have depended on the patient popu-
lation and the deﬁnitions used.20–25 The present study
demonstrated that the slope of the regression line relating
EEM to P&M CSAwithin the lesion was less than the reference
substantiating negative remodelling. Moreover, when other
deﬁnitions of remodelling were used, .80% of lesions in
this diabetic population still had negative remodelling.
The slope of the line relating the change in arterial dimen-
sions to the change in plaque mass over time is the direct
measure of remodelling. A slope .1.0 would indicate posi-
tive remodelling with overcompensation (resulting in net
lumen increase). A slope of 1.0 would indicate perfect posi-
tive remodelling, in which the increase in plaque was exactly
balanced by the increase in EEM CSA, leading to no lumen
change. A slope ,1.0 (or reduction in EEM CSA) would indi-
cate negative remodelling. However, serial studies necessary
to ’directly’ measure remodelling are rare. Instead, indirect
evidence of coronary artery remodelling is obtained using an
index obtained at a single time point, comparing the lesion
site with the reference segment EEM CSA. Positive remodel-
ling refers to a lesion EEM CSA greater than the reference,
whereas negative remodelling refers to a lesion EEM CSA
less than the reference.
Reference segments
In two-thirds of the patients, the reference segment plaque
burden measured .50%. This is in accordance with a pre-
vious study in which the average plaque burden in
angiographically normal reference segments was 50% and
in which diabetes was an independent clinical predictor of
reference segment plaque burden.26 This larger plaque
burden in diabetics is one potential explanation for the
smaller angiographic vessel sizes typically seen in these
patients.27 Another explanation is that the reference seg-
ments may not outwardly remodel as much in diabetics com-
pared with non-diabetics; therefore, the same plaque
accumulation would have a greater impact on reference
lumen dimensions. Since arterial remodelling with compen-
satory EEM enlargement develops to preserve the lumen,
the EEM size by IVUS may be signiﬁcantly greater than the
lumen size by angiography.2 In the present study, although
the QCA–IVUS reference lumen dimension differences corre-
lated with reference plaque burden, the absolute QCA refer-
ence lumen diameter did not; this supports an important
contribution of a reduced outward remodelling to smaller
reference lumen dimensions in diabetics.
Limitations
We did not have serial IVUS studies; instead, we compared
the lesion with the reference to assess remodelling. The
number of patients was too small to do meaningful subset
(i.e. insulin-treated vs. non-insulin-treated patient) analy-
sis. The aim of the present study was to describe remodel-
ling and plaque burden in diabetic patients. Although
these ﬁndings were discussed in comparison with the well-
documented ﬁndings in non-diabetics patients in the litera-
ture, we did not have a matched cohort of non-diabetic
patients. As in other remodelling studies using IVUS,
heavily calciﬁed lesions were excluded when calcium sha-
dowing was .1808, precluding measurement of EEM dimen-
sions. Similarly, as in other remodelling studies using IVUS,
ostial lesions were excluded because of the lack of a proxi-
mal reference segment and because ostial lesions are typi-
cally negatively remodelled even in non-diabetics.
Conclusion
The present IVUS study demonstrates that lesions in type-2
diabetics are characterized by a large reference segment
plaque burden and mostly negative lesion site remodelling.
These IVUS ﬁndings may help to explain the angiographic
appearance of small arteries in diabetic patients.
Conﬂict of interest: none declared.
Figure 5 Relation between the difference between intravascular ultrasound
lumen and quantitative coronary angiography reference diameter and mean
reference plaque burden measured by intravascular ultrasound.
Table 3 Relation between lesion external elastic membrane or plaque and media and lipids
Slope 95% conﬁdence interval P
Lesion EEM volume (mm3) vs. total cholesterol (mmol/L) 221.5 233.0 to 210.0 ,0.001
Lesion EEM volume (mm3) vs. LDL cholesterol (mmol/L) 218.4 232.0 to 24.8 0.010
Lesion EEM volume (mm3) vs. HDL cholesterol (mmol/L) 232.1 256.7 to 27.5 0.011
Lesion P&M volume (mm3) vs. total cholesterol (mmol/L) 215.7 225.6 to 25.7 0.003
Lesion P&M volume (mm3) vs. LDL cholesterol (mmol/L) 212.0 223.8 to 20.3 0.045
Lesion P&M volume (mm3) vs. HDL cholesterol (mmol/L) 224.2 245.0 to 23.3 0.024
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